@article{Jones2021,
title = {Selective laser trabeculoplasty (SLT) performed by optometrists for patients with glaucoma and ocular hypertension: a scoping review},
author = {L. Jones and E. Konstantakopoulou and G. Gazzard
},
url = {https://pubmed.ncbi.nlm.nih.gov/33782653/},
doi = {10.1136/bmjophth-2020-000611},
year = {2021},
date = {2021-03-11},
journal = {BMJ Open Ophthalmology},
abstract = {Selective laser trabeculoplasty (SLT) has been established as an effective treatment to lower intraocular pressure in people with glaucoma and ocular hypertension. The procedure is typically within the remit of ophthalmologists; however, there is potential to upskill optometrists and other healthcare professionals (HCPs) to deliver the treatment. We conducted a scoping review to identify the current global landscape of HCP-delivered SLT and describe training features, clinical effectiveness and safety. Relevant articles were identified through online database searches and grey literature sources. Four articles were selected for full inclusion. This review identified training programmes for optometrist-delivered SLT in the UK and the USA. The findings indicate that more research is needed to clarify training requirements and clinical effectiveness. },
keywords = {glaucoma, treatment lasers},
pubstate = {published},
tppubtype = {article}
}
Selective laser trabeculoplasty (SLT) has been established as an effective treatment to lower intraocular pressure in people with glaucoma and ocular hypertension. The procedure is typically within the remit of ophthalmologists; however, there is potential to upskill optometrists and other healthcare professionals (HCPs) to deliver the treatment. We conducted a scoping review to identify the current global landscape of HCP-delivered SLT and describe training features, clinical effectiveness and safety. Relevant articles were identified through online database searches and grey literature sources. Four articles were selected for full inclusion. This review identified training programmes for optometrist-delivered SLT in the UK and the USA. The findings indicate that more research is needed to clarify training requirements and clinical effectiveness.
@article{Jones2020,
title = {Selective laser trabeculoplasty (SLT) performed by optometrists for patients with glaucoma and ocular hypertension: a scoping review},
author = {L. Jones and E. Konstantakopoulou and G. Gazzard
},
url = {https://bmjophth.bmj.com/content/6/1/e000611},
doi = {10.1136/bmjophth-2020-000438},
year = {2020},
date = {2020-08-26},
journal = {BMJ Open Ophthalmology},
abstract = {Selective laser trabeculoplasty (SLT) has been established as an effective treatment to lower intraocular pressure in people with glaucoma and ocular hypertension. The procedure is typically within the remit of ophthalmologists; however, there is potential to upskill optometrists and other healthcare professionals (HCPs) to deliver the treatment. We conducted a scoping review to identify the current global landscape of HCP-delivered SLT and describe training features, clinical effectiveness and safety. Relevant articles were identified through online database searches and grey literature sources. Four articles were selected for full inclusion. This review identified training programmes for optometrist-delivered SLT in the UK and the USA. The findings indicate that more research is needed to clarify training requirements and clinical effectiveness.},
keywords = {glaucoma, hypertension, laser, optometrists},
pubstate = {published},
tppubtype = {article}
}
Selective laser trabeculoplasty (SLT) has been established as an effective treatment to lower intraocular pressure in people with glaucoma and ocular hypertension. The procedure is typically within the remit of ophthalmologists; however, there is potential to upskill optometrists and other healthcare professionals (HCPs) to deliver the treatment. We conducted a scoping review to identify the current global landscape of HCP-delivered SLT and describe training features, clinical effectiveness and safety. Relevant articles were identified through online database searches and grey literature sources. Four articles were selected for full inclusion. This review identified training programmes for optometrist-delivered SLT in the UK and the USA. The findings indicate that more research is needed to clarify training requirements and clinical effectiveness.
@article{Chandrinos2020,
title = {Methods of Threshold Estimation (Algorithms) and New Techniques in Perimetry: A Review},
author = {A. Chandrinos},
url = {https://www.researchgate.net/publication/342945956_Methods_of_Threshold_Estimation_Algorithms_and_New_Techniques_in_Perimetry_A_Review},
year = {2020},
date = {2020-07-10},
volume = {3},
pages = {21-40},
abstract = {Recently, there have been several new developments in automated perimetry that have contributed to enhanced diagnosis and management of glaucoma. This paper will briefly review the classical algorithms of automated perimetry and also the latest advances in automated perimetry strategies, like SITA Faster algorithm. It will also explore the new algorithms for different perimeters and all the novel techniques, which has been shown to be a rapid, effective method of detecting glaucomatous visual field loss and have demonstrated the ability to predict the onset and progression of glaucomatous visual field deficits.},
keywords = {algorithm, glaucoma, perimetry, testing techniques, threshold},
pubstate = {published},
tppubtype = {article}
}
Recently, there have been several new developments in automated perimetry that have contributed to enhanced diagnosis and management of glaucoma. This paper will briefly review the classical algorithms of automated perimetry and also the latest advances in automated perimetry strategies, like SITA Faster algorithm. It will also explore the new algorithms for different perimeters and all the novel techniques, which has been shown to be a rapid, effective method of detecting glaucomatous visual field loss and have demonstrated the ability to predict the onset and progression of glaucomatous visual field deficits.
@article{Wright2020,
title = {Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)},
author = {D. M. Wright and E. Konstantakopoulou and G. Montesano and N. Nathwani and A. Garg and D. Garway-Heath and D. P. Crabb and G. Gazzard},
url = {https://pubmed.ncbi.nlm.nih.gov/32402553/},
doi = {https://doi.org/10.1016/j.ophtha.2020.03.029},
issn = {0161-6420},
year = {2020},
date = {2020-04-03},
journal = {Ophthalmology},
volume = {127},
pages = {1313-1321},
abstract = {Purpose: To compare visual field outcomes of ocular hypertensive and glaucoma patients treated first with medical therapy with those treated first with selective laser trabeculoplasty (SLT).
Design: Secondary analysis of patients from the Laser in Glaucoma and Ocular Hypertension study, a multicenter randomized controlled trial.
Participants: Three hundred forty-four patients (588 eyes) treated first with medical therapy and 344 patients (590 eyes) treated first with SLT.
Methods: Visual fields (VFs) were measured using standard automated perimetry and arranged in series (median length and duration, 9 VFs over 48 months). Hierarchical linear models were used to estimate pointwise VF progression rates, which were then averaged to produce a global progression estimate for each eye. Proportions of points and patients in each treatment group with fast (<-1 dB/year) or moderate (<-0.5 dB/year) progression were compared using log-binomial regression.
Main outcome measures: Pointwise and global progression rates of total deviation (TD) and pattern deviation (PD).
Results: A greater proportion of eyes underwent moderate or fast TD progression in the medical therapy group compared with the SLT group (26.2% vs. 16.9%; risk ratio [RR], 1.55; 95% confidence interval [CI], 1.23-1.93; P < 0.001). A similar pattern was observed for pointwise rates (medical therapy, 26.1% vs. SLT, 19.0%; RR, 1.37; 95% CI, 1.33-1.42; P < 0.001). A greater proportion of pointwise PD rates were categorized as moderate or fast in the medical therapy group (medical therapy, 11.5% vs. SLT, 8.3%; RR, 1.39; 95% CI, 1.32-1.46; P < 0.001). No statistical difference was found in the proportion of eyes that underwent moderate or fast PD progression (medical therapy, 9.9% vs. SLT, 7.1%; RR, 1.39; 95% CI, 0.95, 2.03; P = 0.0928).
Conclusions: A slightly larger proportion of ocular hypertensive and glaucoma patients treated first with medical therapy underwent rapid VF progression compared with those treated first with SLT.
},
keywords = {glaucoma, hypertension, ophthalmology, visual field},
pubstate = {published},
tppubtype = {article}
}
Purpose: To compare visual field outcomes of ocular hypertensive and glaucoma patients treated first with medical therapy with those treated first with selective laser trabeculoplasty (SLT).
Design: Secondary analysis of patients from the Laser in Glaucoma and Ocular Hypertension study, a multicenter randomized controlled trial.
Participants: Three hundred forty-four patients (588 eyes) treated first with medical therapy and 344 patients (590 eyes) treated first with SLT.
Methods: Visual fields (VFs) were measured using standard automated perimetry and arranged in series (median length and duration, 9 VFs over 48 months). Hierarchical linear models were used to estimate pointwise VF progression rates, which were then averaged to produce a global progression estimate for each eye. Proportions of points and patients in each treatment group with fast (<-1 dB/year) or moderate (<-0.5 dB/year) progression were compared using log-binomial regression.
Main outcome measures: Pointwise and global progression rates of total deviation (TD) and pattern deviation (PD).
Results: A greater proportion of eyes underwent moderate or fast TD progression in the medical therapy group compared with the SLT group (26.2% vs. 16.9%; risk ratio [RR], 1.55; 95% confidence interval [CI], 1.23-1.93; P < 0.001). A similar pattern was observed for pointwise rates (medical therapy, 26.1% vs. SLT, 19.0%; RR, 1.37; 95% CI, 1.33-1.42; P < 0.001). A greater proportion of pointwise PD rates were categorized as moderate or fast in the medical therapy group (medical therapy, 11.5% vs. SLT, 8.3%; RR, 1.39; 95% CI, 1.32-1.46; P < 0.001). No statistical difference was found in the proportion of eyes that underwent moderate or fast PD progression (medical therapy, 9.9% vs. SLT, 7.1%; RR, 1.39; 95% CI, 0.95, 2.03; P = 0.0928).
Conclusions: A slightly larger proportion of ocular hypertensive and glaucoma patients treated first with medical therapy underwent rapid VF progression compared with those treated first with SLT.
@article{Wright2020b,
title = {Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)},
author = {D.M. Wright and E. Konstantakopoulou and G. Montesano and N. Nathwani and A. Garg and D. G. Heath and D.P. Crabb, ; (2020) . , . },
url = {https://pubmed.ncbi.nlm.nih.gov/32402553/},
doi = {10.1016/j.ophtha.2020.03.029},
year = {2020},
date = {2020-04-03},
journal = {Ophthalmology},
volume = {127},
number = {10},
pages = {1313-1321},
keywords = {glaucoma, laser, patient, treatment},
pubstate = {published},
tppubtype = {article}
}
@article{Garg2019,
title = {Laser in Glaucoma and Ocular Hypertension Trial Study Group. Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial},
author = {A. Garg and V. Vickerstaff and N. Nathwani and D.G. Heath and E. Konstantakopoulou and G. Ambler and C. Bunce and R. Wormald and K. Barton and G. Gazzard 2020 Apr },
url = {https://www.researchgate.net/publication/336985146_Efficacy_of_Repeat_Selective_Laser_Trabeculoplasty_in_Medication-Naive_Open_Angle_Glaucoma_and_Ocular_Hypertension_during_the_LiGHT_Trial},
doi = {10.1016/j.ophtha.2019.10.023},
year = {2019},
date = {2019-10-30},
journal = {Ophthalmology},
volume = {127},
number = {4},
pages = {467-476},
note = {Epub 2019 Oct 30},
keywords = {glaucoma, hyper, laser, LiGHT, trabeculoplasty},
pubstate = {published},
tppubtype = {article}
}
